Hualan Biological Engineering Inc. (SHE:002007)
China · Delayed Price · Currency is CNY 15.63
-0.15 (-0.95%)
Jan 30, 2026, 3:04 PM CST
SHE:002007 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 948.62 | 1,088 | 1,482 | 1,076 | 1,299 | 1,613 |
Depreciation & Amortization | 260.64 | 260.64 | 259.59 | 272.82 | 196.45 | 181.66 |
Other Amortization | 11.7 | 11.7 | 14.2 | 14.77 | 10.04 | 5.12 |
Loss (Gain) From Sale of Assets | -0.08 | -0.08 | -44.44 | -47.67 | -0.42 | 0.26 |
Asset Writedown & Restructuring Costs | 5.71 | 5.71 | 9.71 | 1.19 | 3.23 | 0.62 |
Loss (Gain) From Sale of Investments | -170.46 | -170.46 | -209.59 | -144.05 | -100.22 | -110.73 |
Provision & Write-off of Bad Debts | -5.59 | -5.59 | 13.92 | 32.83 | 11.29 | 42.34 |
Other Operating Activities | 285.12 | 154.97 | 384.37 | 358.97 | 309.88 | 274.52 |
Change in Accounts Receivable | 840.46 | 840.46 | -302.66 | -538.11 | 162.97 | -1,247 |
Change in Inventory | -416.88 | -416.88 | -316.45 | -245.23 | -317.36 | -48.7 |
Change in Accounts Payable | -723.83 | -723.83 | 7.97 | 190.01 | -137.32 | 673.69 |
Change in Other Net Operating Assets | 11.15 | 11.15 | 34.82 | 6.36 | 4.14 | 22.44 |
Operating Cash Flow | 1,050 | 1,059 | 1,346 | 957.31 | 1,432 | 1,325 |
Operating Cash Flow Growth | -5.63% | -21.29% | 40.59% | -33.17% | 8.09% | -2.75% |
Capital Expenditures | 53.66 | -255.43 | -753.41 | -393.95 | -811.35 | -621.44 |
Sale of Property, Plant & Equipment | 0.6 | 0.89 | 204.11 | 50.32 | 0.91 | 0.11 |
Divestitures | - | 1.55 | - | - | - | 0.02 |
Investment in Securities | 564.65 | 208.13 | -536.92 | -2,175 | -1,075 | -223.86 |
Other Investing Activities | 189 | 134.93 | 87.94 | 68.89 | 126.6 | 105.79 |
Investing Cash Flow | 807.91 | 90.08 | -998.28 | -2,450 | -1,759 | -739.39 |
Long-Term Debt Issued | - | 596.47 | 700 | 1,100 | 1,300 | 450 |
Long-Term Debt Repaid | - | -700.95 | -600.38 | -1,001 | -700 | -50 |
Total Debt Repaid | -1,630 | -700.95 | -600.38 | -1,001 | -700 | -50 |
Net Debt Issued (Repaid) | -609.46 | -104.48 | 99.62 | 99.24 | 600 | 400 |
Issuance of Common Stock | - | 16.28 | 48.07 | 2,255 | - | 5.02 |
Repurchase of Common Stock | -106.79 | -106.79 | - | - | - | - |
Common Dividends Paid | -331.77 | -467.83 | -563.64 | -399.47 | -564.11 | -571.5 |
Other Financing Activities | 36.18 | -117.62 | -39 | -36.57 | - | -59.72 |
Financing Cash Flow | -1,012 | -780.43 | -454.96 | 1,918 | 35.89 | -226.2 |
Foreign Exchange Rate Adjustments | 0.17 | -0.05 | 0.06 | 0.05 | -0.03 | 0 |
Net Cash Flow | 846.51 | 368.94 | -107.33 | 425.29 | -290.45 | 359.71 |
Free Cash Flow | 1,104 | 803.92 | 592.43 | 563.36 | 621.15 | 703.85 |
Free Cash Flow Growth | 153.17% | 35.70% | 5.16% | -9.30% | -11.75% | -35.41% |
Free Cash Flow Margin | 25.87% | 18.36% | 11.09% | 12.47% | 14.00% | 14.01% |
Free Cash Flow Per Share | 0.60 | 0.44 | 0.33 | 0.31 | 0.34 | 0.39 |
Cash Income Tax Paid | 448.43 | 494.25 | 503.9 | 457.29 | 564.96 | 468.02 |
Levered Free Cash Flow | 2,551 | 492.34 | -696.55 | -498.06 | 252 | 477.44 |
Unlevered Free Cash Flow | 2,556 | 500.43 | -688.32 | -479.15 | 265.58 | 480.54 |
Change in Working Capital | -285.4 | -285.4 | -563.51 | -607.8 | -296.66 | -681.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.